New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 21, 2014
07:09 EDTISRGIntuitive Surgical initiated with a Strong Buy at ISI Group
Target $500.
News For ISRG From The Last 14 Days
Check below for free stories on ISRG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
17:01 EDTISRGOn The Fly: Closing Wrap
Stocks began the session mixed and remained that way throughout the trading day, with the Nasdaq the leader and the Dow the laggard. The tech-heavy Nasdaq was helped by a post-earnings rise in shares of Apple (AAPL), while the blue-chip index was weighed down by Boeing's (BA) under-performance following its own quarter report. There was little movement in the averages during the day as they remained in a narrow range, but the increase in the S&P 500 did manage to push it to a new all-time closing high. After the bell, investors will receive the next wave of earnings with AT&T (T), Facebook (FB) and Qualcomm (QCOM) scheduled to report. ECONOMIC EVENTS: In the U.S., MBA's mortgage market index rose 2.4%, with a 0.3% rise in the purchase index and a 4.1% gain in the refinance index for the week ended July 18. Also, the International Monetary Fund predicted that U.S. economic growth for 2014 as a whole will be a disappointing 1.7%. However, barring unforeseen shocks, 2015 growth should accelerate to the fastest annual pace since 2005, propelled by strong consumption growth, a declining fiscal drag, a pickup in residential investment, and easy financial conditions, said the IMF. COMPANY NEWS: Shares of Apple advanced $2.47, or 2.61%, to $97.19 after reporting third quarter earnings that beat expectations. However, the iPhone maker's revenue came in a bit short of analyst expectations for its just completed quarter and its guidance for sales in the new quarter was also below expectations. Piper Jaffray analyst Gene Munster said Apple's September quarter guidance suggests an iPhone 6 launch on September 26, versus the firm's prior expectation for a September 19 launch. Piper views Apple's Q3 results as removing the last major variable ahead of the iPhone and iWatch launches later this year and reiterates an Overweight rating on the stock. Another research firm, Janney Capital, said Apple did not address rumored new products, like the iPhone 6 and iWatch, on its earnings call, but did indicate that its wider than normal revenue guidance range was due to "many moving pieces," suggesting one or two new products may be introduced, but late in the quarter... Dow component Boeing sank $3.03, or 2.34%, to $126.71 despite reporting "core" EPS that beat expectations and raising its fiscal year earnings outlook to a range above the Wall Street consensus. Boeing's revenue missed expectations, however, and it also reported its total company backlog of $440B was unchanged from the beginning of the quarter... Another Dow member, McDonald's (MCD), fell 92c, or 0.96%, to $95.35 after the company reported weaker than expected second quarter results yesterday and its stock was downgraded by at least five research firms. MAJOR MOVERS: Among the notable gainers was Puma Biotechnology (PBYI), whose stock surged $174.40, or 295.44%, to $233.43 after the company reported positive data for its breast cancer drug and an analyst at Citigroup said that the company would probably become a takeover target. Also higher was Intuitive Surgical (ISRG), which rose $69.47, or 17.71%, to $461.63 and was upgraded at both Raymond James and Stifel after the company reported better than expected Q2 results. Among the noteworthy losers was Xilinx (XLNX), which tumbled $6.89, or 14.31%, to $41.26 after the company reported lower than expected first quarter revenue and forecast that its sales could drop as much as 4% in Q2 versus Q1. After the report, analysts at William Blair, Bank of America Merrill Lynch and BMO Capital all downgraded the stock. Also lower were shares of Juniper Networks (JNPR), which fell $2.39, or 9.63%, to $22.43 and was also downgraded at Bank of America Merrill Lynch after its Q3 guidance missed expectations. INDEXES: The Dow slid 26.91, or 0.16%, to 17,086.63, the Nasdaq rose 17.68, or 0.4%, to 4,473.70, and the S&P 500 gained 3.48, or 0.18%, to 1,987.01.
13:36 EDTISRGIntuitive Surgical rises after Q2 EPS, revenue beat expectations
Subscribe for More Information
12:17 EDTISRGOn The Fly: Midday Wrap
Subscribe for More Information
10:02 EDTISRGOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:17 EDTISRGOn The Fly: Pre-market Movers
Subscribe for More Information
08:46 EDTISRGIntuitive Surgical fundamentals improving, says JMP Securities
After Intuitive Surgical reported better than expected results, JMP Securities thinks the company's headwinds are moderating, and the firm recommends buying the stock.
07:18 EDTISRGIntuitive Surgical price target raised to $500 from $465 at Jefferies
Subscribe for More Information
05:50 EDTISRGIntuitive Surgical upgraded to Buy from Hold at Stifel
Stifel upgraded Intuitive Surgical to Buy with a $600 price target following the company's better than expected Q2 results. Shares were also upgraded this morning at Raymond James.
05:49 EDTISRGIntuitive Surgical upgraded to Outperform from Market Perform at Raymond James
Subscribe for More Information
July 22, 2014
18:33 EDTISRGOn The Fly: After Hours Movers
UP AFTER EARNINGS: Broadcom (BRCM), consensus up 3% after reporting second quarter results... Intuitive Surgical (ISRG), up 10.4%... Manhattan Associates (MANH), up 3%... Robert Half International (RHI), up 3.9%... Hawaiian Holdings (HA), up 3.1%... Microsoft (MSFT), up just under 1%... FMC Technologies (FTI), up 1.1%. ALSO HIGHER: Ballard Power Systems (BLDP), up 2.7% following purchase order from New Flyer Industries... Unwired Planet (UPIP), up 2.4% after filing a lawsuit against Microsoft for breach of contract. NOTABLE: Puma Biotechnology (PBYI), up 193.8% after reporting positive top line results from Phase III PB272 trial. DOWN AFTER EARNINGS: Xilinx (XLNX), down 8.7%... Apple (AAPL), down after reporting third quarter results and fourth quarter guidance... Juniper Networks (JNPR), down 4.7%... ALSO LOWER: Farmland Partners (FPI), down 3.8% after filing to sell 3.72M shares of common stock.
17:00 EDTISRGIntuitive Surgical narrows FY14 procedure growth view to 5%-8% from 2%-8%
Subscribe for More Information
16:57 EDTISRGIntuitive Surgical sees international procedure growth 'lumpy' QoQ
Subscribe for More Information
16:39 EDTISRGIntuitive Surgical sees capital pressures in most hospitals to continue
Subscribe for More Information
16:17 EDTISRGIntuitive Surgical reports Q2 adjusted EPS $3.73, GAAP EPS $2.77
Consensus $2.83. Intuitive Surgical ended Q2 with $2B in cash, cash equivalents, and investments, a decrease of $920M during the quarter, primarily reflecting the impact of $1B utilized during the quarter to repurchase shares of its common stock.
16:13 EDTISRGIntuitive Surgical rises after results, first look
Subscribe for More Information
16:06 EDTISRGIntuitive Surgical reports Q2 EPS $2.77, consensus $2.83
Subscribe for More Information
15:30 EDTISRGNotable companies reporting after market close
Subscribe for More Information
13:57 EDTISRGEarnings Preview: Intuitive Surgical share price flat over last 12 months
Subscribe for More Information
11:36 EDTISRGIntuitive Surgical July weekly volatility increases into Q2 and outlook
Subscribe for More Information
July 18, 2014
07:37 EDTISRGIntuitive Surgical Q2 expectations 'appear achievable,' says Jefferies
Jefferies says its hospital and surgeon channel checks increase its comfort level around initial Xi demand and overall placements ahead of Intuitive Surgical's Q2 results, though the firm cautions that visibility on utilization is low and procedures could come in below consensus. Jefferies thinks expectations for Q2 "appear achievable" since they incorporate near-term challenges. The firm keeps a Buy rating on the stock with a $465 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use